In conclusion, the serum levels of CK-18-M30, FGF21, IL-1Ra, PEDF and OPG were strongly associated with NASH progression and may serve as biomarkers of NASH identification. The gene discussed is TNFRSF11B; the disease is metabolic dysfunction-associated steatohepatitis.